Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipotoxicity”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Post-approval studies (Phase 4)WithdrawnNCT00745953
What this trial is testing

Regression of Fatty Heart by Valsartan Therapy

Who this might be right for
Metabolic SyndromeLipotoxicity
University of Texas Southwestern Medical Center
Not applicableStudy completedNCT03836443
What this trial is testing

Postprandial Lipotoxicity and Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Assistance Publique - Hôpitaux de Paris 30
Post-approval studies (Phase 4)Looking for participantsNCT05838287
What this trial is testing

Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

Who this might be right for
Type 2 Diabetes Mellitus in ObeseHeart Failure With Preserved Ejection Fraction
The University of Texas Health Science Center at San Antonio 78
Not applicableLooking for participantsNCT07364045
What this trial is testing

Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS)

Who this might be right for
Type 2 Diabetes
University of Edinburgh 104
Not applicableStudy completedNCT01346527
What this trial is testing

Fat Metabolism in Pregnancy and Neonatal Heart Function in Diabetes

Who this might be right for
Type 2 DiabetesPregnancy
Washington University School of Medicine 79
Post-approval studies (Phase 4)Study completedNCT00746174
What this trial is testing

Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving Rosiglitazone

Who this might be right for
Insulin Sensitivity
University of Texas Southwestern Medical Center 24
Large-scale testing (Phase 3)Study completedNCT01816165
What this trial is testing

Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Colorado, Denver 28
Very early researchStudy completedNCT01358409
What this trial is testing

Regression of Myocardial Steatosis by Nebivolol

Who this might be right for
Cardiac Steatosis and Lipotoxicity
Lidia Szczepaniak 31
Not applicableStudy completedNCT01520454
What this trial is testing

Effect of Increased Free Fatty Acids on Leptin Function

Who this might be right for
ObesityLeptin Resistance
Beth Israel Deaconess Medical Center 26
Not applicableStudy completedNCT05761145
What this trial is testing

Sphingo-lipotoxicity and Trans-differentiation of Adipose Tissue in Obesity (SFINGOTRANS)

Who this might be right for
ObesityHealthy
Istituto Auxologico Italiano 84
Testing effectiveness (Phase 2)Looking for participantsNCT05912621
What this trial is testing

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

Who this might be right for
ObesityOverweight and ObesityOverweight
Stanford University 66
Not applicableUnknownNCT03111771
What this trial is testing

Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract

Who this might be right for
Cancer of Upper Aerodigestive PathwaysCachexia
University Hospital, Clermont-Ferrand 60